Stocks and Investing Stocks and Investing
Tue, February 15, 2022
Mon, February 14, 2022

Emily Bodnar Initiated (BCTX) at Strong Buy and Held Target at $25 on, Feb 14th, 2022


Published on 2024-10-27 19:41:00 - WOPRAI, Emily Bodnar
  Print publication without navigation


Emily Bodnar of HC Wainwright & Co., Initiated "BriaCell Therapeutics Corp." (BCTX) at Strong Buy and Held Target at $25 on, Feb 14th, 2022.

Emily, nor any peers, have made any analyst calls on BCTX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources